X4 Pharmaceuticals (XFOR) Gross Profit (QoQ) (2024 - 2025)

X4 Pharmaceuticals (XFOR) Gross Profit (QoQ) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 65,899.61 Bn 65,899.33 Bn -
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn -
3 Akari Therapeutics 1,022.34 Bn 1,022.34 Bn -
4 BeOne Medicines 472.68 Bn 467.89 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.24 Bn 114.99 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.08 Bn 61.33 Bn 3.31 Bn
7 Belite Bio 62.46 Bn 62.46 Bn -
8 Argenx Se 55.93 Bn 50.75 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.59 Bn 34.58 Bn 959.66 Mn
10 X4 Pharmaceuticals 165.58 Mn -51.47 Mn 2.20 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 55.87%
Sep 30, 2025 -14.15%
Jun 30, 2025 -93.16%
Mar 31, 2025 2,028.18%
Dec 31, 2024 239.94%
Sep 30, 2024 12.88%